<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26579397</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2211-3835</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Acta pharmaceutica Sinica. B</Title><ISOAbbreviation>Acta Pharm Sin B</ISOAbbreviation></Journal><ArticleTitle>Curcumin inhibits the replication of enterovirus 71 in vitro.</ArticleTitle><Pagination><StartPage>284</StartPage><EndPage>294</EndPage><MedlinePgn>284-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.apsb.2014.06.006</ELocationID><Abstract><AbstractText>Human enterovirus 71 (EV71) is the main causative pathogen of hand, foot, and mouth disease (HFMD) in children. The epidemic of HFMD has been a public health problem in Asia-Pacific region for decades, and no vaccine and effective antiviral medicine are available. Curcumin has been used as a traditional medicine for centuries to treat a diversity of disorders including viral infections. In this study, we demonstrated that curcumin showed potent antiviral effect again EV71. In Vero cells infected with EV71, the addition of curcumin significantly suppressed the synthesis of viral RNA, the expression of viral protein, and the overall production of viral progeny. Similar with the previous reports, curcumin reduced the production of ROS induced by viral infection. However, the antioxidant property of curcumin did not contribute to its antiviral activity, since N-acetyl-l-cysteine, the potent antioxidant failed to suppress viral replication. This study also showed that extracellular signal-regulated kinase (ERK) was activated by either viral infection or curcumin treatment, but the activated ERK did not interfere with the antiviral effect of curcumin, indicating ERK is not involved in the antiviral mechanism of curcumin. Unlike the previous reports that curcumin inhibited protein degradation through ubiquitin-proteasome system (UPS), we found that curcumin had no impact on UPS in control cells. However, curcumin did reduce the activity of proteasomes which was increased by viral infection. In addition, the accumulation of the short-lived proteins, p53 and p21, was increased by the treatment of curcumin in EV71-infected cells. We further probed the antiviral mechanism of curcumin by examining the expression of GBF1 and PI4KB, both of which are required for the formation of viral replication complex. We found that curcumin significantly reduced the level of both proteins. Moreover, the decreased expression of either GBF1 or PI4KB by the application of siRNAs was sufficient to suppress viral replication. We also demonstrated that curcumin showed anti-apoptotic activity at the early stage of viral infection. The results of this study provide solid evidence that curcumin has potent anti-EV71 activity. Whether or not the down-regulated GBF1 and PI4KB by curcumin contribute to its antiviral effect needs further studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Xiaoning</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianying</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin 150086, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Acta Pharm Sin B</MedlineTA><NlmUniqueID>101600560</NlmUniqueID><ISSNLinking>2211-3835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">CVB, coxsackieviurs B</Keyword><Keyword MajorTopicYN="N">Curcumin</Keyword><Keyword MajorTopicYN="N">DCFH-DA, dichloro-dihydro-fluorescein diacetate</Keyword><Keyword MajorTopicYN="N">ERK, extracellular signal-regulated kinase</Keyword><Keyword MajorTopicYN="N">EV71, enterovirus 71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">GBF1</Keyword><Keyword MajorTopicYN="N">GBF1, Golgi brefeldin A resistant guanine nucleotide exchange factor 1</Keyword><Keyword MajorTopicYN="N">GEF, guanine nucleotide exchange factor</Keyword><Keyword MajorTopicYN="N">HBV, hepatitis B virus</Keyword><Keyword MajorTopicYN="N">HCV, hepatitis C virus</Keyword><Keyword MajorTopicYN="N">HFMD, hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">HIV, human immunodeficiency virus</Keyword><Keyword MajorTopicYN="N">HPV, human papillomavirus</Keyword><Keyword MajorTopicYN="N">NAC, N-acetyl-l-cysteine</Keyword><Keyword MajorTopicYN="N">PARP-1, poly(ADP-ribose) polymerase</Keyword><Keyword MajorTopicYN="N">PGC-1&#x3b1;, peroxisome proliferator-activated receptor-gamma co-activator 1 alpha</Keyword><Keyword MajorTopicYN="N">PI4KB</Keyword><Keyword MajorTopicYN="N">PI4KB, phosphatidylinositol 4-kinase class III catalytic subunit &#x3b2;</Keyword><Keyword MajorTopicYN="N">PI4P, phosphatidylinositol 4-phosphate</Keyword><Keyword MajorTopicYN="N">ROS, reactive oxygen species</Keyword><Keyword MajorTopicYN="N">SLLVY-AMC, succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin</Keyword><Keyword MajorTopicYN="N">UPS, ubiquitin&#x2013;proteasome system</Keyword><Keyword MajorTopicYN="N">Ubiquitin&#x2013;proteasome system</Keyword><Keyword MajorTopicYN="N">Viral replication</Keyword><Keyword MajorTopicYN="N">p.i., post-infection</Keyword><Keyword MajorTopicYN="N">siRNA, small interfering RNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26579397</ArticleId><ArticleId IdType="pmc">PMC4629085</ArticleId><ArticleId IdType="doi">10.1016/j.apsb.2014.06.006</ArticleId><ArticleId IdType="pii">S2211-3835(14)00058-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology. 2011;412:91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">21262515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Lau S.K., Lo J.Y., Chan K.H., Woo P.C., Yuen K.Y. Genetic characterization of EV71 isolates from 2004 to 2010 reveals predominance and persistent circulation of the newly proposed genotype D and recent emergence of a distinct lineage of subgenotype C2 in Hong Kong. Virol J. 2013;10:222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3716818</ArticleId><ArticleId IdType="pubmed">23822185</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z.L., Mao Q.Y., Wang Y.P., Zhu F.C., Li J.X., Yao X. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother. 2013;9:1701&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906269</ArticleId><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Dong C., Li X., Gao Q., Guo Z., Yao X. Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One. 2012;7:e46043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460965</ArticleId><ArticleId IdType="pubmed">23029378</ArticleId></ArticleIdList></Reference><Reference><Citation>Premanand B., Kiener T.K., Meng T., Tan Y.R., Jia Q., Chow V.T. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Antiviral Res. 2012;95:311&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">22691220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.Y., Chen D.Y., Wen H.W., Ou J.L., Chiou S.S., Chen J.M. Inhibition of enveloped viruses infectivity by curcumin. PLoS One. 2013;8:e62482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641039</ArticleId><ArticleId IdType="pubmed">23658730</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Wu K., Li S.H., You Q. Protective effect of curcumin against cardiac dysfunction in sepsis rats. Pharm Biol. 2013;51:482&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">23336318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Yin H., Wang L., Shuboy A., Lou J., Han B. Curcumin as a potential treatment for Alzheimer&#x5f3;s disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med. 2013;41:59&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">23336507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita T., Makino Y. Novel curcumin oral delivery systems. Anticancer Res. 2013;33:2807&#x2013;2821.</Citation><ArticleIdList><ArticleId IdType="pubmed">23780965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehzad A., Rehman G., Lee Y.S. Curcumin in inflammatory diseases. Biofactors. 2013;39:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">23281076</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorafshan A., Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des. 2013;19:2032&#x2013;2046.</Citation><ArticleIdList><ArticleId IdType="pubmed">23116311</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami A., Furukawa I., Miyamoto S., Tanaka T., Ohigashi H. Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis. Biofactors. 2013;39:221&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">23233214</ArticleId></ArticleIdList></Reference><Reference><Citation>Anggakusuma, Colpitts C.C., Schang L.M., Rachmawati H., Frentzen A., Pfaender S. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2013;63:1137&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pubmed">23903236</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan A., Kehn-Hall K., Senina S., Lundberg L., van Duyne R., Guendel I. Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem. 2012;287:33198&#x2013;33214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3460426</ArticleId><ArticleId IdType="pubmed">22847000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K., Ramedani E., Mohammadi K., Tajbakhsh S., Deilami I., Rastian Z. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat Prod Commun. 2010;5:1935&#x2013;1938.</Citation><ArticleIdList><ArticleId IdType="pubmed">21299124</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechtman M.M., Har-Noy O., Bar-Yishay I., Fishman S., Adamovich Y., Shaul Y. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett. 2010;584:2485&#x2013;2490.</Citation><ArticleIdList><ArticleId IdType="pubmed">20434445</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajragupta O., Boonchoong P., Morris G.M., Olson A.J. Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett. 2005;15:3364&#x2013;3368.</Citation><ArticleIdList><ArticleId IdType="pubmed">15950462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.H., Lee M.Y., Chuang J.J., Li Y.Z., Ning S.T., Chen J.C. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Int J Mol Med. 2012;30:1021&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573749</ArticleId><ArticleId IdType="pubmed">22922731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutluay S.B., Doroghazi J., Roemer M.E., Triezenberg S.J. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 2008;373:239&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668156</ArticleId><ArticleId IdType="pubmed">18191976</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X., Wang Y., Wong J., Zhang J., McManus B.M., Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol. 2007;81:3142&#x2013;3150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866032</ArticleId><ArticleId IdType="pubmed">17229707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Li X., Zhao W., Tong L., Liu J., Wu S. Mutations at nucleotides 573 and 579 within 5&#x2032;-untranslated region augment the virulence of coxsackievirus B1. Virus Res. 2008;135:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">18514346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopegamage S., Kovacova J., Vargova A., Motusova J., Petrovicova A., Benkovicova M. Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol. 2005;86:3271&#x2013;3280.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L., Lin L., Wu S., Guo Z., Wang T., Qin Y. MiR-10a&#x204e; up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 2013;41:3760&#x2013;3771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616696</ArticleId><ArticleId IdType="pubmed">23389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.S., Ruan Z., Sang W.W. HDAC1/NFkappaB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. J Cell Physiol. 2011;226:3385&#x2013;3391.</Citation><ArticleIdList><ArticleId IdType="pubmed">21344388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Kim K.H., Kim H.Y., Cho H.K., Sakamoto N., Cheong J. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett. 2010;584:707&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">20026048</ArticleId></ArticleIdList></Reference><Reference><Citation>Baugh M.A. HIV: reactive oxygen species, enveloped viruses and hyperbaric oxygen. Med Hypotheses. 2000;55:232&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">10985915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Zuo Y., Li B., Wang H., Liu H., Wang X. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-kappaB inhibition and p53 reactivation in human lung cancer cells. Mol Cancer Ther. 2013;12:1381&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">23696216</ArticleId></ArticleIdList></Reference><Reference><Citation>Tharakan B., Hunter F.A., Smythe W.R., Childs E.W. Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock. Clin Exp Pharmacol Physiol. 2010;37:939&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">20528978</ArticleId></ArticleIdList></Reference><Reference><Citation>Derochette S., Franck T., Mouithys-Mickalad A., Ceusters J., Deby-Dupont G., Lejeune J.P. Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. Chem Biol Interact. 2013;206:186&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">24060679</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon H.J., Ko W.K., Han S.W., Kim D.S., Hwang Y.S., Park H.K. Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation. Biochem Biophys Res Commun. 2012;418:247&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">22252298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W.R., Chen Y.Y., Yang S.M., Chen Y.L., Horng J.T. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 2005;78:82&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094582</ArticleId><ArticleId IdType="pubmed">16150462</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple J.I., Smits V.A., Fernaud J.R., Mamely I., Freire R. Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome. Cell Death Differ. 2007;14:1433&#x2013;1442.</Citation><ArticleIdList><ArticleId IdType="pubmed">17431426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimnaugh E.G., Xu W., Vos M., Yuan X., Neckers L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res. 2006;4:667&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">16966435</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S., Yang J.M., Hait W.N. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase. Cancer Res. 2005;65:3806&#x2013;3810.</Citation><ArticleIdList><ArticleId IdType="pubmed">15867377</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer M.L., Theodosiou M., Noonan D.J. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif. J Biol Chem. 2004;279:37069&#x2013;37078.</Citation><ArticleIdList><ArticleId IdType="pubmed">15229225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wang C. PAX3-FKHR transformation increases 26S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression. J Biol Chem. 2003;278:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">12401804</ArticleId></ArticleIdList></Reference><Reference><Citation>Si X., Gao G., Wong J., Wang Y., Zhang J., Luo H. Ubiquitination is required for effective replication of coxsackievirus B3. PLoS One. 2008;3:e2585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2440516</ArticleId><ArticleId IdType="pubmed">18612413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitagawa Y., Yamaguchi M., Zhou M., Nishio M., Itoh M., Gotoh B. Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7- and TLR9-dependent interferon induction. J Virol. 2013;87:7966&#x2013;7976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3700191</ArticleId><ArticleId IdType="pubmed">23678181</ArticleId></ArticleIdList></Reference><Reference><Citation>Maelfait J., Beyaert R. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev. 2012;76:33&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3294425</ArticleId><ArticleId IdType="pubmed">22390971</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Zhu K., Cheng H. Ubiquitination in host immune response to human papillomavirus infection. Arch Dermatol Res. 2011;303:217&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">21400034</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi H., Herschenhous N., Kuzushita N., Moss S.F. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. Cancer Res. 2003;63:4739&#x2013;4746.</Citation><ArticleIdList><ArticleId IdType="pubmed">12907657</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla S.L., Rodriguez A., Gonzales M.M., Gallego G.J., Castano O.J. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Arch Virol. 2014;159:573&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">24081825</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K., Ghosh D., Basu A. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J Neuroimmune Pharmacol. 2009;4:328&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">19434500</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L., van der Schaar H.M., Lanke K.H., Neyts J., van Kuppeveld F.J. Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication. J Virol. 2010;84:7535&#x2013;7542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897619</ArticleId><ArticleId IdType="pubmed">20504936</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C.L., Ma Y.G., Xue Y.X., Liu Y.Y., Xie H., Qiu G.R. Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway. DNA Cell Biol. 2012;31:139&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">21711158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav B., Taurin S., Larsen L., Rosengren R.J. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells. Int J Oncol. 2012;41:1119&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">22710975</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar H.M., van der Linden L., Lanke K.H., Strating J.R., Purstinger G., de Vries E. Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication. Cell Res. 2012;22:1576&#x2013;1592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494396</ArticleId><ArticleId IdType="pubmed">22945356</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M.X., Zhao L., Deng C., Yang L., Wang Y., Guo T. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. Int J Oncol. 2013;43:1951&#x2013;1959.</Citation><ArticleIdList><ArticleId IdType="pubmed">24064724</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger K.L., Cooper J.D., Heaton N.S., Yoon R., Oakland T.E., Jordan T.X. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci USA. 2009;106:7577&#x2013;7582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678598</ArticleId><ArticleId IdType="pubmed">19376974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Z., Xing J., Yu X. Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway. Tumour Biol. 2014;35:753&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959480</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri M.S., Nebozyhn M., Raymond A., Gekonge B., Hancock A., Creer S. Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J Immunol. 2009;182:4459&#x2013;4470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2776064</ArticleId><ArticleId IdType="pubmed">19299747</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng G.C., Maguen B., Jin L., Mott K.R., Osorio N., Slanina S.M. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J Virol. 2002;76:1224&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135864</ArticleId><ArticleId IdType="pubmed">11773398</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomonosova E., Subramanian T., Chinnadurai G. Requirement of BAX for efficient adenovirus-induced apoptosis. J Virol. 2002;76:11283&#x2013;11290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136755</ArticleId><ArticleId IdType="pubmed">12388688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Sulcove J., Frank I., Jaffer S., Ozdener H., Kolson D.L. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway. J Virol. 2002;76:9407&#x2013;9419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136431</ArticleId><ArticleId IdType="pubmed">12186923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Li J., Liu T., Wang L., Li Y. MRI characteristics of brainstem encephalitis in hand-foot-mouth disease induced by enterovirus type 71-will different MRI manifestations be helpful for prognosis? Eur J Paediatr Neurol. 2013;17:486&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">23561930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaaloul I., Riabi S., Harrath R., Evans M., Salem N.H., Mlayeh S. Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular pathology diagnosis at post-mortem. BMC Infect Dis. 2012;12:212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3462138</ArticleId><ArticleId IdType="pubmed">22966951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L.M., Zheng H.Y., Zheng H.Z., Guo X., He J.F., Guan D.W. An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis. 2011;64:13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21266750</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.J., Lai C.C., Lai C.H., Sue S.C., Lin C.W., Hung C.H. Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. Eur J Med Chem. 2013;62:206&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">23353754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.Y., Liu Y.C., Jheng J.R., Tsai H.P., Jan J.T., Wong W.R. Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities. Am J Chin Med. 2009;37:143&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">19222118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B.W., Pan T.L., Leu Y.L., Chang Y.K., Tai P.J., Lin K.H. Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med. 2007;35:153&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">17265559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou J.L., Mizushina Y., Wang S.Y., Chuang D.Y., Nadar M., Hsu W.L. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J. 2013;280:5829&#x2013;5840.</Citation><ArticleIdList><ArticleId IdType="pubmed">24034558</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M.A., Levander O.A., Handy J. Selenium deficiency and viral infection. J Nutr. 2003;133:1463S&#x2013;1467SS.</Citation><ArticleIdList><ArticleId IdType="pubmed">12730444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez R.M., Berria M.I., Levander O.A. Host selenium status selectively influences susceptibility to experimental viral myocarditis. Biol Trace Elem Res. 2001;80:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11393307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Leu Y.L., Chiu D.T. Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem. 2009;57:6140&#x2013;6147.</Citation><ArticleIdList><ArticleId IdType="pubmed">19537794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Chang L., Yeh T.T., Shih S.R. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol. 2008;89:2080&#x2013;2089.</Citation><ArticleIdList><ArticleId IdType="pubmed">18753216</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Lee I.T., Yang C.M. Enterovirus 71 induces integrin beta1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication. J Cell Physiol. 2011;226:3316&#x2013;3329.</Citation><ArticleIdList><ArticleId IdType="pubmed">21321939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang H., Zhu M., Luo Z., Peng Y. MEK1-ERKs signal cascade is required for the replication of enterovirus 71 (EV71) Antiviral Res. 2012;93:110&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem. 2005;280:30091&#x2013;30099.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Shan Q., Gong Y., Lin J., Shi F., Shi R. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells. Pharmazie. 2014;69:229&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">24716415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y., Hong Y., Zong H., Wang Y., Zou W., Yang J. CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin&#x2013;proteasome degradation. Biochem Biophys Res Commun. 2009;386:493&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">19538938</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan K., Zheng Z., Song T., He X., Xu C., Zhang Y. MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltage-dependent anion channel 1. Mol Cell Biol. 2013;33:3137&#x2013;3149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753917</ArticleId><ArticleId IdType="pubmed">23754752</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Luo X., Lu Y., Zhu T., Wang J., Tsun A. Ubiquitination signals critical to regulatory T cell development and function. Int Immunopharmacol. 2013;16:348&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhy S.U., Kim K., Larsen L., Rosengren R.J., Safe S. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer. 2012;12:564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522018</ArticleId><ArticleId IdType="pubmed">23194063</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J.Y., Liu Z.Q. Feruloylacetone as the model compound of half-curcumin: synthesis and antioxidant properties. Eur J Med Chem. 2011;46:1198&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">21330013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanke K.H., van der Schaar H.M., Belov G.A., Feng Q., Duijsings D., Jackson C.L. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol. 2009;83:11940&#x2013;11949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772713</ArticleId><ArticleId IdType="pubmed">19740986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E., Duijsings D., Lanke K.H., Melchers W.J., Jackson C.L., van Kuppeveld F.J. Molecular determinants of the interaction between coxsackievirus protein 3A and guanine nucleotide exchange factor GBF1. J Virol. 2007;81:5238&#x2013;5245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900206</ArticleId><ArticleId IdType="pubmed">17329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Kojima H., Nagano T., Okabe T., Wakita T., Shimizu H. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol. 2011;85:2364&#x2013;2372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067798</ArticleId><ArticleId IdType="pubmed">21177810</ArticleId></ArticleIdList></Reference><Reference><Citation>Borawski J., Troke P., Puyang X., Gibaja V., Zhao S., Mickanin C. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol. 2009;83:10058&#x2013;10074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2748049</ArticleId><ArticleId IdType="pubmed">19605471</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger K.L., Randall G. Potential roles for cellular cofactors in hepatitis C virus replication complex formation. Commun Integr Biol. 2009;2:471&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2829822</ArticleId><ArticleId IdType="pubmed">20195453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>